Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Studies in animals have documented that, compared with glucose, dietary fructose induces dyslipidemia and insulin resistance. To assess the relative effects of these dietary sugars during sustained consumption in humans, overweight and obese subjects consumed glucose- or fructose-sweetened beverages providing 25% of energy requirements for 10 weeks. Although both groups exhibited similar weight gain during the intervention, visceral adipose volume was significantly increased only in subjects consuming fructose. Fasting plasma triglyceride concentrations increased by approximately 10% during 10 weeks of glucose consumption but not after fructose consumption. In contrast, hepatic de novo lipogenesis (DNL) and the 23-hour postprandial triglyceride AUC were increased specifically during fructose consumption. Similarly, markers of altered lipid metabolism and lipoprotein remodeling, including fasting apoB, LDL, small dense LDL, oxidized LDL, and postprandial concentrations of remnant-like particle-triglyceride and -cholesterol significantly increased during fructose but not glucose consumption. In addition, fasting plasma glucose and insulin levels increased and insulin sensitivity decreased in subjects consuming fructose but not in those consuming glucose. These data suggest that dietary fructose specifically increases DNL, promotes dyslipidemia, decreases insulin sensitivity, and increases visceral adiposity in overweight/obese adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Habitual consumption of significant amounts ( . 10% energy) of dietary fructose contributes to TG elevations, particularly in people with HTG.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The impact of fructose/sucrose intake on HDL-C does not seem different from that of other refined carbohydrates.158,159”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Sucrose, a disaccharidecontaining glucose and fructose, represents an important source of fructose in the diet. 158,175”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Fructose has emerged as a potent activator of carbohydrate response element-binding protein (ChREBP), which is particularly relevant in the context of MASLD, given the global rise in fructose consumption that parallels the increasing prevalence of MASLD [78- 82].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [81]
Experimental — accuracy not yet measuredIn the citing paper
“dietary fructose contributes to TG elevations; these effects are dose dependent and become clinically relevant when the intake is .10%energy daily-with a habitual fructose consumption between 15 and 20% of the energy intake, plasma TG increases as much as 30 -40%.”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [76]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
A new predictive equation for resting energy expenditure in healthy individuals
Mifflin, M., St Jeor, S., Hill, L., Scott, B., Daugherty, S., & Koh, Y. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.2.241 · Cited by 2,544 · cited 1×
“calculated by the Mifflin equation (67), with an adjustment of 1.”
MethodNordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 1×
“Diacylglycerol is a known activator of novel PKC (51), and increases of both diacylglycerol and novel PKC activity are associated with lipid-induced insulin resistance (52, 53).”
BackgroundItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Lipoprotein lipase: structure, function, regulation, and role in disease
Mead, J., Irvine, S., & Ramji, D. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0384-9 · Cited by 927
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Self-citationMorino, K., Petersen, K. F., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-s002 · Cited by 853 · cited 1×
“We propose that the increased hepatic lipid resulting from fructose-induced DNL leads to hepatic insulin resistance (49, 50), possibly by increasing levels of diacylglycerol (49).”
BackgroundConway, J. M., Ingwersen, L. A., Vinyard, B. T., & Moshfegh, A. J. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1171 · Cited by 820
Research works printed but not linked: 1
- Schwarz, J.M., Neese, R.A., Schakleton, C., and Hellerstein, M.K. 1993. De novo lipogenesis during fasting and oral fructose ingestion in lean and obese hyperinsulinemic subjects [abstract]. Diabetes. 42 :A39.
Cited by
Items 101–200 of 1,008
Fructose: It’s “Alcohol Without the Buzz”
Lustig, R. H. (2013) · Advances in Nutrition · doi:10.3945/an.112.002998 · Cited by 240
Hauner, H., Bechthold, A., Boeing, H., Brönstrup, A., Buyken, A., Leschik-Bonnet, E., Linseisen, J., Schulze, M., Strohm, D., & Wolfram, G. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000335326 · Cited by 233
High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ Functions
Zhang, D.-M., Jiao, R.-Q., & Kong, L.-D. (2017) · Nutrients · doi:10.3390/nu9040335 · Cited by 228
Aragno, M., & Mastrocola, R. (2017) · Nutrients · doi:10.3390/nu9040385 · Cited by 239
“S veral studies have dem strated that exc ssive fructose consumption is associ te with increased ectopic lipid deposition in l ver and skeletal muscle b th in experimental models and in humans [48,49,54,55], and that fru tose is able to promote hepatic lipogenesis [56,57] by inducing the expression and activation of t…”
BackgroundGeidl-Flueck, B., Hochuli, M., Németh, Á., Eberl, A., Derron, N., Köfeler, H. C., Tappy, L., Berneis, K., Spinas, G. A., & Gerber, P. A. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.027 · Cited by 238
Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat
Schwarz, J.-M., Noworolski, S. M., Wen, M. J., Dyachenko, A., Prior, J. L., Weinberg, M. E., Herraiz, L. A., Tai, V. W., Bergeron, N., Bersot, T. P., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3678 · Cited by 229
Self-citationFructose ingestion acutely stimulates circulating FGF21 levels in humans
Dushay, J. R., Toschi, E., Mitten, E. K., Fisher, F. M., Herman, M. A., & Maratos-Flier, E. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2014.09.008 · Cited by 233
Bray, G. A. (2013) · Advances in Nutrition · doi:10.3945/an.112.002816 · Cited by 218
Khan, T. A., & Sievenpiper, J. L. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1345-3 · Cited by 214
Metabolic drivers of non-alcoholic fatty liver disease
Bence, K. K., & Birnbaum, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101143 · Cited by 221
A Longitudinal Analysis of Sugar-Sweetened Beverage Intake in Infancy and Obesity at 6 Years
Pan, L., Li, R., Park, S., Galuska, D. A., Sherry, B., & Freedman, D. S. (2014) · Pediatrics · doi:10.1542/peds.2014-0646f · Cited by 215
Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management
Marjot, T., Moolla, A., Cobbold, J. F., Hodson, L., & Tomlinson, J. W. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz009 · Cited by 228
Sugary drink consumption and risk of cancer: results from NutriNet-Santé prospective cohort
Chazelas, E., Srour, B., Desmetz, E., Kesse-Guyot, E., Julia, C., Deschamps, V., Druesne-Pecollo, N., Galan, P., Hercberg, S., Latino-Martel, P., et al. (2019) · BMJ · doi:10.1136/bmj.l2408 · Cited by 225
Gugliucci, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013912 · Cited by 225
Functionality of sugars in foods and health
Clemens, R. A., Jones, J. M., Kern, M., Lee, S., Mayhew, E. J., Slavin, J. L., & Zivanovic, S. (2016) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12194 · Cited by 224
Role of Fructose-Containing Sugars in the Epidemics of Obesity and Metabolic Syndrome
Stanhope, K. L. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-042010-113026 · Cited by 220
Self-citationAl-Jawaldeh, A., & Abbass, M. M. S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.817808 · Cited by 177
The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease
Nomura, K., & Yamanouchi, T. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.09.006 · Cited by 211
Health implications of fructose consumption: A review of recent data
Rizkalla, S. W. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-82 · Cited by 202
Daniels, M. C., & Popkin, B. M. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00311.x · Cited by 209
Brown Adipose Tissue—A Translational Perspective
Carpentier, A. C., Blondin, D. P., Haman, F., & Richard, D. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac015 · Cited by 198
Moderate Amounts of Fructose Consumption Impair Insulin Sensitivity in Healthy Young Men
Aeberli, I., Hochuli, M., Gerber, P. A., Sze, L., Murer, S. B., Tappy, L., Spinas, G. A., & Berneis, K. (2013) · Diabetes Care · doi:10.2337/dc12-0540 · Cited by 203
Stanhope, K. L., Schwarz, J.-M., & Havel, P. J. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283613bca · Cited by 203
Self-citationChREBP regulates fructose-induced glucose production independently of insulin signaling
Kim, M.-S., Krawczyk, S. A., Doridot, L., Fowler, A. J., Wang, J. X., Trauger, S. A., Noh, H.-L., Kang, H. J., Meissen, J. K., Blatnik, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81993 · Cited by 212
High fructose corn syrup and diabetes prevalence: A global perspective
Goran, M. I., Ulijaszek, S. J., & Ventura, E. E. (2013) · Global Public Health · doi:10.1080/17441692.2012.736257 · Cited by 204
Liver and diabetes. A vicious circle
Loria, P., Lonardo, A., & Anania, F. (2013) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01031.x · Cited by 208
Soft drinks consumption and nonalcoholic fatty liver disease
Nseir, W. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i21.2579 · Cited by 201
The Role of Diet in the Pathogenesis of Cholesterol Gallstones
Di Ciaula, A., Garruti, G., Frühbeck, G., De Angelis, M., de Bari, O., Wang, D. Q.-H., Lammert, F., & Portincasa, P. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170530080636 · Cited by 196
Butler, A. A., Tam, C. S., Stanhope, K. L., Wolfe, B. M., Ali, M. R., O'Keeffe, M., St-Onge, M.-P., Ravussin, E., & Havel, P. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2194 · Cited by 206
Self-citationRippe, J. M., & Angelopoulos, T. J. (2013) · Advances in Nutrition · doi:10.3945/an.112.002824 · Cited by 194
Patterns of food consumption among vegetarians and non-vegetarians
Orlich, M. J., Jaceldo-Siegl, K., Sabaté, J., Fan, J., Singh, P. N., & Fraser, G. E. (2014) · British Journal of Nutrition · doi:10.1017/s000711451400261x · Cited by 191
Role of diet and nutritional management in non‐alcoholic fatty liver disease
Fan, J., & Cao, H. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12244 · Cited by 191
Duffey, K. J., Gordon-Larsen, P., Steffen, L. M., Jacobs, D. R., & Popkin, B. M. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29478 · Cited by 195
Animal models of NAFLD from a hepatologist's point of view
Jahn, D., Kircher, S., Hermanns, H. M., & Geier, A. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.023 · Cited by 194
Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.
Pacifico, L., Nobili, V., Anania, C., Verdecchia, P., & Chiesa, C. (2011) · PubMed · doi:10.3748/wjg.v17.i26.3082 · Cited by 198
Mellor, K. M., Bell, J. R., Young, M. J., Ritchie, R. H., & Delbridge, L. M. D. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.03.002 · Cited by 198
Kelishadi, R., Mansourian, M., & Heidari-Beni, M. (2014) · Nutrition · doi:10.1016/j.nut.2013.08.014 · Cited by 199
Yu, J., Marsh, S., Hu, J., Feng, W., & Wu, C. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/2862173 · Cited by 199
Johnston, R. D., Stephenson, M. C., Crossland, H., Cordon, S. M., Palcidi, E., Cox, E. F., Taylor, M. A., Aithal, G. P., & Macdonald, I. A. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.012 · Cited by 193
Lustig, R. H., Mulligan, K., Noworolski, S. M., Tai, V. W., Wen, M. J., Erkin‐Cakmak, A., Gugliucci, A., & Schwarz, J. (2016) · Obesity · doi:10.1002/oby.21371 · Cited by 184
Self-citationUric Acid as a Cause of the Metabolic Syndrome
King, C., Lanaspa, M. A., Jensen, T., Tolan, D. R., Sánchez-Lozada, L. G., & Johnson, R. J. (2018) · Contributions to Nephrology · doi:10.1159/000484283 · Cited by 187
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.012 · Cited by 192
David Wang, D., Sievenpiper, J. L., de Souza, R. J., Cozma, A. I., Chiavaroli, L., Ha, V., Mirrahimi, A., Carleton, A. J., Di Buono, M., Jenkins, A. L., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.10.019 · Cited by 191
“, 2009 [25] k 32 OW/OB”
BackgroundInfluentialThe role of fructose transporters in diseases linked to excessive fructose intake
Douard, V., & Ferraris, R. P. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2011.215731 · Cited by 185
Blevins, J. E., Graham, J. L., Morton, G. J., Bales, K. L., Schwartz, M. W., Baskin, D. G., & Havel, P. J. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00441.2014 · Cited by 187
Self-citationAbdelmalek, M. F., Lazo, M., Horska, A., Bonekamp, S., Lipkin, E. W., Balasubramanyam, A., Bantle, J. P., Johnson, R. J., Diehl, A. M., & Clark, J. M. (2012) · Hepatology · doi:10.1002/hep.25741 · Cited by 190
“In overweight or obese adults, consumption of fructose-sweetened, but not glucose-sweetened, beverages increases de novo lipogenesis, promotes dyslipidemia, impairs insulin sensitivity, and increases visceral adiposity.(11) Furthermore, a longitudinal study of women (n 1⁄4 91,249) followed up over 8 years showed that…”
BackgroundToward a unifying hypothesis of metabolic syndrome
Bremer, A. A., Mietus-Snyder, M., & Lustig, R. H. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2912 · Cited by 186
Self-citationDiet and exercise in NAFLD/NASH: Beyond the obvious
Semmler, G., Datz, C., Reiberger, T., & Trauner, M. (2021) · Liver International · doi:10.1111/liv.15024 · Cited by 179
“Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis
Febbraio, M. A., & Karin, M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.004 · Cited by 173
Fernando, D. H., Forbes, J. M., Angus, P. W., & Herath, C. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205037 · Cited by 184
“Consumption of sugar-sweetened food has increased in the last couple of decades and is positively correlated with metabolic syndrome [79,80], dyslipidemia and insulin resistance [81,82].”
BackgroundZonation of glucose and fatty acid metabolism in the liver: Mechanism and metabolic consequences
Hijmans, B. S., Grefhorst, A., Oosterveer, M. H., & Groen, A. K. (2014) · Biochimie · doi:10.1016/j.biochi.2013.06.007 · Cited by 169
Small Dense LDL Cholesterol and Coronary Heart Disease: Results from the Framingham Offspring Study
Ai, M., Otokozawa, S., Asztalos, B. F., Ito, Y., Nakajima, K., White, C. C., Cupples, L. A., Wilson, P. W., & Schaefer, E. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.137489 · Cited by 180
Self-citationBarrière, D. A., Noll, C., Roussy, G., Lizotte, F., Kessai, A., Kirby, K., Belleville, K., Beaudet, N., Longpré, J.-M., Carpentier, A. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18896-5 · Cited by 171
Diets and nonalcoholic fatty liver disease: The good and the bad
Asrih, M., & Jornayvaz, F. R. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2013.11.003 · Cited by 175
Dietary fructose causes tubulointerstitial injury in the normal rat kidney
Nakayama, T., Kosugi, T., Gersch, M., Connor, T., Sanchez-Lozada, L. G., Lanaspa, M. A., Roncal, C., Perez-Pozo, S. E., Johnson, R. J., & Nakagawa, T. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00433.2009 · Cited by 179
Postprandial lipoprotein metabolism: VLDL vs chylomicrons
Nakajima, K., Nakano, T., Tokita, Y., Nagamine, T., Inazu, A., Kobayashi, J., Mabuchi, H., Stanhope, K. L., Havel, P. J., Okazaki, M., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.018 · Cited by 168
Self-citationA review of recent evidence relating to sugars, insulin resistance and diabetes
Macdonald, I. A. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1340-8 · Cited by 160
Dietary Fats and Health: Dietary Recommendations in the Context of Scientific Evidence
Lawrence, G. D. (2013) · Advances in Nutrition · doi:10.3945/an.113.003657 · Cited by 174
The Effect of Fructose on Renal Biology and Disease
Johnson, R. J., Sanchez-Lozada, L. G., & Nakagawa, T. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050506 · Cited by 170
Ha, V., Sievenpiper, J. L., de Souza, R. J., Chiavaroli, L., Wang, D. D., Cozma, A. I., Mirrahimi, A., Yu, M. E., Carleton, A. J., Dibuono, M., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.182311 · Cited by 176
Johnson, R. K., Lichtenstein, A. H., Anderson, C. A. M., Carson, J. A., Després, J.-P., Hu, F. B., Kris-Etherton, P. M., Otten, J. J., Towfighi, A., Wylie-Rosett, J., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000569 · Cited by 176
Heterogeneous Effects of Fructose on Blood Lipids in Individuals With Type 2 Diabetes
Sievenpiper, J. L., Carleton, A. J., Chatha, S., Jiang, H. Y., de Souza, R. J., Beyene, J., Kendall, C. W. C., & Jenkins, D. J. A. (2009) · Diabetes Care · doi:10.2337/dc09-0619 · Cited by 176
Silbernagel, G., Machann, J., Unmuth, S., Schick, F., Stefan, N., Häring, H. U., & Fritsche, A. (2011) · British Journal of Nutrition · doi:10.1017/s000711451000574x · Cited by 172
Honey - A Novel Antidiabetic Agent
Erejuwa, O. O., Sulaiman, S. A., & Wahab, M. S. A. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.3697 · Cited by 166
Gout and Diet: A Comprehensive Review of Mechanisms and Management
Zhang, Y., Chen, S., Yuan, M., Xu, Y., & Xu, H. (2022) · Nutrients · doi:10.3390/nu14173525 · Cited by 197
Sugar Intake, Obesity, and Diabetes in India
Gulati, S., & Misra, A. (2014) · Nutrients · doi:10.3390/nu6125955 · Cited by 165
Johnson, R. J., Sánchez-Lozada, L. G., Andrews, P., & Lanaspa, M. A. (2017) · Advances in Nutrition · doi:10.3945/an.116.014654 · Cited by 159
Muriel, P., López-Sánchez, P., & Ramos-Tovar, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136969 · Cited by 156
A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism
Fisher, F. M., Kim, M., Doridot, L., Cunniff, J. C., Parker, T. S., Levine, D. M., Hellerstein, M. K., Hudgins, L. C., Maratos-Flier, E., & Herman, M. A. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2016.11.008 · Cited by 166
Self-citation2017 Taiwan lipid guidelines for high risk patients
Li, Y.-H., Ueng, K.-C., Jeng, J.-S., Charng, M.-J., Lin, T.-H., Chien, K.-L., Wang, C.-Y., Chao, T.-H., Liu, P.-Y., Su, C.-H., et al. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.11.013 · Cited by 157
Nikolic, D., Katsiki, N., Montalto, G., Isenovic, E., Mikhailidis, D., & Rizzo, M. (2013) · Nutrients · doi:10.3390/nu5030928 · Cited by 159
Molecular mechanisms of hypolipidemic effects of curcumin
Zingg, J., Hasan, S. T., & Meydani, M. (2013) · BioFactors · doi:10.1002/biof.1072 · Cited by 161
Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD)
Syed‐Abdul, M. M. (2023) · Metabolites · doi:10.3390/metabo14010012 · Cited by 180
DiNicolantonio, J. J., O’Keefe, J. H., & Lucan, S. C. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.12.019 · Cited by 179
Schwartz, E., Tzulker, R., Glazer, I., Bar-Ya’akov, I., Wiesman, Z., Tripler, E., Bar‐Ilan, I., Fromm, H., Borochov‐Neori, H., Holland, D., et al. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf901466c · Cited by 169
Sugar consumption and global prevalence of obesity and hypertension: an ecological analysis
Siervo, M., Montagnese, C., Mathers, J. C., Soroka, K. R., Stephan, B. C., & Wells, J. C. (2014) · Public Health Nutrition · doi:10.1017/s1368980013000141 · Cited by 157
Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter
Lodhi, I. J., Wei, X., & Semenkovich, C. F. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.09.002 · Cited by 151
Koopman, K. E., Caan, M. W. A., Nederveen, A. J., Pels, A., Ackermans, M. T., Fliers, E., la Fleur, S. E., & Serlie, M. J. (2014) · Hepatology · doi:10.1002/hep.27149 · Cited by 154
Cox, C. L., Stanhope, K. L., Schwarz, J. M., Graham, J. L., Hatcher, B., Griffen, S. C., Bremer, A. A., Berglund, L., McGahan, J. P., Keim, N. L., et al. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-68 · Cited by 154
Self-citationPharmacology biochemistry and behavior
(1979) · Brain Research Bulletin · doi:10.1016/s0361-9230(79)80031-3 · Cited by 159
Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
Yki-Järvinen, H. (2015) · Nutrients · doi:10.3390/nu7115454 · Cited by 154
Ultraprocessed Food: Addictive, Toxic, and Ready for Regulation
Lustig, R. H. (2020) · Nutrients · doi:10.3390/nu12113401 · Cited by 167
Phenotyping the effect of diet on non-alcoholic fatty liver disease
de Wit, N. J. W., Afman, L. A., Mensink, M., & Müller, M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.003 · Cited by 150
Johnson, R. J., Lanaspa, M. A., & Gaucher, E. A. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.08.002 · Cited by 167
Patterns and trends of beverage consumption among children and adults in Great Britain, 1986–2009
Ng, S. W., Ni Mhurchu, C., Jebb, S. A., & Popkin, B. M. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511006465 · Cited by 148
Lonardo, A., Mantovani, A., Lugari, S., & Targher, G. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.03.001 · Cited by 150
Fructose consumption: recent results and their potential implications
Stanhope, K. L., & Havel, P. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05266.x · Cited by 147
Self-citationSex hormone-binding globulin gene expression in the liver: Drugs and the metabolic syndrome
PUGEAT, M. M., Nader, N., Hogeveen, K. N., Raverot, G., Déchaud, H., & Grenot, C. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.020 · Cited by 176
Chan, S. M. H., Sun, R.-Q., Zeng, X.-Y., Choong, Z.-H., Wang, H., Watt, M. J., & Ye, J.-M. (2013) · Diabetes · doi:10.2337/db12-1397 · Cited by 146
Bremer, A. A., Stanhope, K. L., Graham, J. L., Cummings, B. P., Wang, W., Saville, B. R., & Havel, P. J. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00298.x · Cited by 148
Self-citationSugar-Sweetened and Artificially-Sweetened Beverages in Relation to Obesity Risk
Pereira, M. A. (2014) · Advances in Nutrition · doi:10.3945/an.114.007062 · Cited by 161
Effects of a short-term overfeeding with fructose or glucose in healthy young males
Ngo Sock, E. T., Lê, K.-A., Ith, M., Kreis, R., Boesch, C., & Tappy, L. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509992819 · Cited by 141
Calorie‐sweetened beverages and fructose: what have we learned 10 years later
Bray, G. A., & Popkin, B. M. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2013.00171.x · Cited by 143
The Role of High-Fructose Corn Syrup in Metabolic Syndrome and Hypertension
Ferder, L., Ferder, M., & Inserra, F. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0097-3 · Cited by 166
ATF4 Protein Deficiency Protects against High Fructose-induced Hypertriglyceridemia in Mice
Xiao, G., Zhang, T., Yu, S., Lee, S., Calabuig-Navarro, V., Yamauchi, J., Ringquist, S., & Dong, H. H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470526 · Cited by 140
Intestinal Fructose and Glucose Metabolism in Health and Disease
Merino, B., Fernández-Díaz, C. M., Cózar‐Castellano, I., & Perdomo, G. (2019) · Nutrients · doi:10.3390/nu12010094 · Cited by 166
Simopoulos, A. P. (2013) · Nutrients · doi:10.3390/nu5082901 · Cited by 161
Ren, L.-P., Chan, S. M. H., Zeng, X.-Y., Laybutt, D. R., Iseli, T. J., Sun, R.-Q., Kraegen, E. W., Cooney, G. J., Turner, N., & Ye, J.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030816 · Cited by 140
Lecoultre, V., Egli, L., Carrel, G., Theytaz, F., Kreis, R., Schneiter, P., Boss, A., Zwygart, K., Lê, K., Bortolotti, M., et al. (2013) · Obesity · doi:10.1002/oby.20377 · Cited by 135
Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD)
Alwahsh, S. M., & Gebhardt, R. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1892-7 · Cited by 148
Metadata
- Authors
- Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., McGahan, J. P., Seibert, A., Krauss, R. M., Chiu, S., Schaefer, E. J., Ai, M., Otokozawa, S., Nakajima, K., Nakano, T., Beysen, C., Hellerstein, M. K., Berglund, L., & Havel, P. J.
- Affiliations
- University of California, Davis (US)
- University of California, San Francisco (US)
- United States Department of Agriculture (US)
- Touro University California (US)
- UCSF Benioff Children's Hospital (US)
- Tufts University (US)
- KineMed (United States) (US)
- VA Northern California Health Care System (US)
- Corresponding author
- Havel, Peter J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2009-05-01
- Volume
- 119
- Issue
- 5
- Pages
- 1322-1334
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2673878
- OpenAlex
- W2146966453
- Cited by
- 1,765
- References
- 86
- Citations by year
- 2026: 56 · 2025: 73 · 2024: 56 · 2023: 96 · 2022: 92 · 2021: 101 · 2020: 113 · 2019: 112 · 2018: 135 · 2017: 105 · 2016: 118 · 2015: 121 · 2014: 135 · 2013: 143 · 2012: 108
- FWCI
- 74.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Diabetes Association (UL1 RR024146)
- U.S. Department of Agriculture (5306‐51530‐016‐00D, UL1 RR024146)
- Bristol-Myers Squibb
- Pfizer
- Sanofi
- American College of Radiology Imaging Network
- School of Veterinary Medicine, University of California, Davis
- KineMed
- Novo Nordisk
- Otsuka Pharmaceutical
- National Institutes of Health (AT‐003545, 5r01hl075675-05, 5r01hl091333-02, HL‐091333, R01 HL-075675, HL‐075675, RR024146)
- University of California, Davis (95616, RR024146, UL1 RR024146)
- Agricultural Research Service (5306‐51530‐016‐00D)
- National Heart, Lung, and Blood Institute (R01 HL-075675, R01 HL-091333, HL-091333, R01HL107256)
- National Center for Research Resources (RR-024146, 5306-51530-016-00D, UL1RR024146)
- National Center for Complementary and Integrative Health (AT0-02993, AT0-03545, AT 002599, R21AT002993, R21AT002599)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- dietary fructose, glucose, visceral fat, insulin resistance, insulin sensitivity, dyslipidemia, hepatic de novo lipogenesis, triglycerides, lipoprotein remodeling, oxidized LDL, remnant-like particles, overweight and obesity, weight gain
- MeSH terms
- Beverages, Blood Glucose, Body Weight, Energy Intake, Double-Blind Method, Eating, Female, Fructose, Glucose, Humans, Insulin, Insulin Resistance, Lipids, Lipoproteins, Liver, Male, Middle Aged, Models, Biological, Obesity, Sex Characteristics, Triglycerides, Gene Expression, Dietary Sucrose, Subcutaneous Fat, Intra-Abdominal Fat, Overweight, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.